Compare Tilray Brands Inc (TLRY) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Tilray Brands Inc trades at $3.54 (market cap $530.54M), while State Street SPDR S&P Homebuilders ETF trades at $94.77 (market cap $1.49B). The key difference: State Street SPDR S&P Homebuilders ETF is far larger — about 2.8× Tilray Brands Inc's market cap, and Tilray Brands Inc is more actively traded (9,099,075 versus 2,445,587). Which is the better fit depends on your goals — on Pluang, investors hold Tilray Brands Inc for 31 Days and State Street SPDR S&P Homebuilders ETF for 33 Days on average.
| TLRY | XHB | |
|---|---|---|
Market Cap | $530.54M | $1.49B |
Volume | 9,099,075 | 2,445,587 |
Sector | Health | Broad Market / Factor |
52-Week High | $17.20 | $121.36 |
52-Week Low | $3.54 | $94.77 |
Typical Hold Time | 31 Days | 33 Days |
Enterprise Value | $684.46M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TLRY trades at $3.59, down 3.36% on the day and near 52-week lows, with a bearish technical signal. The company reported revenue of $821.31M for 2025 but posted a net loss of -$2.19B, missing earnings expectations for four consecutive quarters. While analyst consensus shows 70% hold ratings, the stock faces significant profitability challenges with negative margins and cash flow concerns despite some revenue growth projections.
The outlook remains challenging with persistent losses and negative cash flow, though the stock trades at discounted valuation multiples. Key risks include ongoing profitability struggles and cannabis regulatory uncertainty. Potential catalysts include upcoming Q1 2027 earnings on October 8, 2026, and potential marijuana reform developments that could benefit the company's positioning.
XHB (SPDR S&P Homebuilders ETF) trades at $95.66, up 0.81% with a bearish technical signal from moving averages. The ETF faces headwinds from rising mortgage rates above 7% but shows potential catalysts from new housing legislation and institutional interest. Recent news highlights mixed housing data with June new home sales rising 1.6% while existing home sales declined 2.4%, creating uncertainty in the housing sector.
The homebuilder ETF presents a contrarian opportunity amid sector weakness, with historical valuation signals suggesting potential rebounds. Key risks include persistent high mortgage rates and housing affordability challenges, while positive catalysts include institutional accumulation and government housing support measures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About State Street SPDR S&P Homebuilders ETF
XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.
Read more on XHB →
